InvestSMART

Microba Life Sciences Limited (ASX: MAP) - Announcements

Current share price for MAP : $0.054 0.006 (12.50%)+

ASX company news and announcements for Microba Life Sciences Limited (MAP) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Microba Life Sciences Limited (MAP) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Microba Life Sciences Limited (MAP), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Microba Life Sciences Limited (MAP)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 Results of General Meeting 8 Aug 2025 2:37PM $0.091 $0.054 fallen by 40.66%
$39 Q4 FY25 Quarterly Investor Presentation & Webinar 22 Jul 2025 8:58AM $0.095 $0.054 fallen by 43.16%
$39 Q4 FY25 Quarterly Activities Report & Appendix 4C 22 Jul 2025 8:57AM $0.095 $0.054 fallen by 43.16%
$39 Details of Q4 FY25 Quarterly Report, Appendix 4C & Webinar 17 Jul 2025 12:26PM $0.092 $0.054 fallen by 41.30%
$39 Letter to Shareholders, Notice of EGM & Proxy Form 8 Jul 2025 4:04PM $0.088 $0.054 fallen by 38.64%
$39 Ceasing to be a substantial holder 2 Jul 2025 3:56PM $0.085 $0.054 fallen by 36.47%
$39 Cleansing Notice 27 Jun 2025 11:38AM $0.084 $0.054 fallen by 35.71%
$39 Letter to SPP Eligible Shareholders 27 Jun 2025 11:37AM $0.084 $0.054 fallen by 35.71%
$39 Disclosure Document - Prospectus 27 Jun 2025 11:37AM $0.084 $0.054 fallen by 35.71%
$39 Application for quotation of securities - MAP 27 Jun 2025 9:51AM $0.084 $0.054 fallen by 35.71%
$39 Reinstatement to Quotation 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Proposed issue of securities - MAP 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Strategic Investment & Equity Raise Presentation 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Microba secures $14.5 million to drive clinical adoption 23 Jun 2025 12:35PM $0.115 $0.054 fallen by 53.04%
$39 Suspension from Quotation 23 Jun 2025 10:56AM $0.115 $0.054 fallen by 53.04%
$39 Trading Halt 19 Jun 2025 9:28AM $0.115 $0.054 fallen by 53.04%
$39 MetaPanel Pathogen Study Delivers Breakthrough Results 21 May 2025 9:12AM $0.160 $0.054 fallen by 66.25%
$39 Landmark GI Study Results from over 4,600 patients 14 May 2025 9:02AM $0.175 $0.054 fallen by 69.14%
$39 Notification of cessation of securities - MAP 12 May 2025 5:08PM $0.175 $0.054 fallen by 69.14%
$39 Q3 FY25 Quarterly Investor Presentation & Webinar 30 Apr 2025 9:23AM $0.225 $0.054 fallen by 76%
$39 Q3 FY25 Quarterly Activities Report & Appendix 4C 30 Apr 2025 9:22AM $0.225 $0.054 fallen by 76%
$39 Details of Q3 FY25 Quarterly Report, Appendix 4C & Webinar 28 Apr 2025 2:33PM $0.190 $0.054 fallen by 71.58%

76 - 100 of 693 results

Page 4 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.